Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 20 Categorisation of clinical trials of products under Article 2a paragraph 2 TPA 27

1 Clin­ic­al tri­als of products un­der Art­icle 2a para­graph 2 TPA come un­der Cat­egory A if:

a.
the product that is un­der in­vest­ig­a­tion has been re­por­ted pur­su­ant to Art­icle 6 para­graph 3 MedDO28 in its ver­sion of 1 Janu­ary 200229 in ap­plic­a­tion of Art­icle 108 para­graph 1 let­ter b MedDO; and
b.
it is used in ac­cord­ance with the in­struc­tions.

2 They come un­der Cat­egory C if:

a.
das product that is un­der in­vest­ig­a­tion has not been re­por­ted pur­su­ant to Art­icle 6 para­graph 3 MedDO in its ver­sion of 1 Janu­ary 2002 in ap­plic­a­tion of Art­icle 108 para­graph 1 let­ter b MedDO;
b.
the product that is un­der in­vest­ig­a­tion is not used in ac­cord­ance with the in­ten­ded pur­poses spe­cified in the in­struc­tions; or
c.
use of the product that is un­der in­vest­ig­a­tion is pro­hib­ited in Switzer­land.

27 Amended by An­nex 2 No 2 of the O of 4 May 2022, in force since 26 May 2022 (AS 2022 294).

28 SR 812.213

29 AS 2001 3487

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback